153 related articles for article (PubMed ID: 21331767)
1. ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration.
Wakatsuki T; Irisawa A; Terashima M; Shibukawa G; Takagi T; Imamura H; Takahashi Y; Sato A; Sato M; Ikeda T; Suzuki R; Hikichi T; Obara K; Ohira H
Int J Clin Oncol; 2011 Aug; 16(4):387-94. PubMed ID: 21331767
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.
Ma G; Sun Y; Fu S
Int J Clin Exp Pathol; 2015; 8(10):13284-8. PubMed ID: 26722531
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer.
Ashida R; Nakata B; Shigekawa M; Mizuno N; Sawaki A; Hirakawa K; Arakawa T; Yamao K
J Exp Clin Cancer Res; 2009 Jun; 28(1):83. PubMed ID: 19531250
[TBL] [Abstract][Full Text] [Related]
4. The absence of class III β-tubulin is predictive of a favorable response to nab-paclitaxel and gemcitabine in patients with unresectable pancreatic ductal adenocarcinoma.
Kato A; Naiki-Ito A; Naitoh I; Hayashi K; Nakazawa T; Shimizu S; Nishi Y; Okumura F; Inoue T; Takada H; Kondo H; Yoshida M; Takahashi S; Joh T
Hum Pathol; 2018 Apr; 74():92-98. PubMed ID: 29339176
[TBL] [Abstract][Full Text] [Related]
5. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.
Fujita H; Ohuchida K; Mizumoto K; Itaba S; Ito T; Nakata K; Yu J; Kayashima T; Souzaki R; Tajiri T; Manabe T; Ohtsuka T; Tanaka M
Neoplasia; 2010 Oct; 12(10):807-17. PubMed ID: 20927319
[TBL] [Abstract][Full Text] [Related]
6. Heat Shock Protein 27 Expression in EUS-FNA Samples Can Predict Gemcitabine Sensitivity in Pancreatic Cancer.
Kawano M; Kaino S; Amano S; Shinoda S; Suenaga S; Sen-Yo M; Sakaida I
In Vivo; 2018; 32(3):637-642. PubMed ID: 29695571
[TBL] [Abstract][Full Text] [Related]
7. Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy.
Yamada R; Mizuno S; Uchida K; Yoneda M; Kanayama K; Inoue H; Murata Y; Kuriyama N; Kishiwada M; Usui M; Ii N; Tsuboi J; Tano S; Hamada Y; Tanaka K; Horiki N; Ogura T; Shiraishi T; Takei Y; Katayama N; Isaji S
Pancreas; 2016; 45(5):761-71. PubMed ID: 26784908
[TBL] [Abstract][Full Text] [Related]
8. Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer.
Eto K; Kawakami H; Kuwatani M; Kudo T; Abe Y; Kawahata S; Takasawa A; Fukuoka M; Matsuno Y; Asaka M; Sakamoto N
Br J Cancer; 2013 Apr; 108(7):1488-94. PubMed ID: 23492684
[TBL] [Abstract][Full Text] [Related]
9. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
10. Increasing Number of Passes Beyond 4 Does Not Increase Sensitivity of Detection of Pancreatic Malignancy by Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
Mohamadnejad M; Mullady D; Early DS; Collins B; Marshall C; Sams S; Yen R; Rizeq M; Romanas M; Nawaz S; Ulusarac O; Hollander T; Wilson RH; Simon VC; Kushnir V; Amateau SK; Brauer BC; Gaddam S; Azar RR; Komanduri S; Shah R; Das A; Edmundowicz S; Muthusamy VR; Rastogi A; Wani S
Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1071-1078.e2. PubMed ID: 28025154
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas.
Itoi T; Sofuni A; Fukushima N; Itokawa F; Tsuchiya T; Kurihara T; Moriyasu F; Tsuchida A; Kasuya K
J Gastroenterol; 2007 May; 42(5):389-94. PubMed ID: 17530364
[TBL] [Abstract][Full Text] [Related]
12. EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer.
Levy MJ; Alberts SR; Bamlet WR; Burch PA; Farnell MB; Gleeson FC; Haddock MG; Kendrick ML; Oberg AL; Petersen GM; Takahashi N; Chari ST
Gastrointest Endosc; 2017 Jul; 86(1):161-169. PubMed ID: 27889543
[TBL] [Abstract][Full Text] [Related]
13. Effect of pancreatic juice cytology and/or endoscopic ultrasound-guided fine-needle aspiration biopsy for pancreatic tumor.
Matsumoto K; Takeda Y; Harada K; Horie Y; Yashima K; Murawaki Y
J Gastroenterol Hepatol; 2014 Jan; 29(1):223-7. PubMed ID: 23869654
[TBL] [Abstract][Full Text] [Related]
14. A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.
Hirooka Y; Kasuya H; Ishikawa T; Kawashima H; Ohno E; Villalobos IB; Naoe Y; Ichinose T; Koyama N; Tanaka M; Kodera Y; Goto H
BMC Cancer; 2018 May; 18(1):596. PubMed ID: 29801474
[TBL] [Abstract][Full Text] [Related]
15. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.
Hecht JR; Bedford R; Abbruzzese JL; Lahoti S; Reid TR; Soetikno RM; Kirn DH; Freeman SM
Clin Cancer Res; 2003 Feb; 9(2):555-61. PubMed ID: 12576418
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the diagnostic yield of endoscopic ultrasonography-guided fine-needle aspiration in patients with a suspected pancreatic malignancy.
Yang L; Iwai T; Kida M; Yamauchi H; Okuwaki K; Imaizumi H; Kaneko T; Hasegawa R; Miyata E; Wasaburo K
Rev Esp Enferm Dig; 2018 Sep; 110(9):544-550. PubMed ID: 30032635
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study.
Vainshtein JM; Schipper M; Zalupski MM; Lawrence TS; Abrams R; Francis IR; Khan G; Leslie W; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):96-101. PubMed ID: 23265573
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Early Recurrence With In Vitro Adenosine Triphosphate Based Chemotherapy Response Assay in Pancreas Cancer With Postoperative Gemcitabine Chemotherapy.
Park JS; Kim JK; Yoon DS
J Clin Lab Anal; 2016 Nov; 30(6):804-810. PubMed ID: 26991127
[TBL] [Abstract][Full Text] [Related]
19. Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine.
Sawaki A; Kanemitsu Y; Mizuno N; Takahashi K; Nakamura T; Ioka T; Tanaka S; Nakaizumi A; Salem AA; Ueda R; Yamao K
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1292-7. PubMed ID: 18700899
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: a prospective study.
Wittmann J; Kocjan G; Sgouros SN; Deheragoda M; Pereira SP
Cytopathology; 2006 Feb; 17(1):27-33. PubMed ID: 16417562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
